ENDOPROTECH, INC.
Medtech · Private
A therapeutic agent that alters endothelial cell lipid content to prevent reperfusion injury and no-reflow phenomenon during percutaneous coronary intervention for heart attack
- Grants
- $3.9M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 2 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Novel Drug Carrier System for the Treatment of Alcoholic Liver Disease | $664,616 | |
| Federal grant | Department of Health and Human Services · Phase I · A Novel Lipotherapy to Reduce Infarct Size Following Myocardial Infarction | $224,812 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel Drug Carrier System for the Treatment of Alcoholic Liver Disease | $749,725 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Lipotherapy to Reduce Infarct Size Following Myocardial Infarction | $1,485,754 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Lipotherapy to Reduce Infarct Size Following Myocardial Infarction | $736,042 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1836 | GRADIENT MEDICAL, INC. | — | — |
| 1837 | NEUROINDX INC. | — | — |
| 1838 | NAMI DIAGNOSTICS LLC | — | — |
| 1839 | ENDOPROTECH, INC. | — | — |
| 1840 | SUBTLE MEDICAL, INC. | — | — |
| 1841 | Enable Biosciences Inc. | — | — |
| 1842 | Irenix Medical, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Treating Microvascular Dysfunctiongranted
- Treating Microvascular Dysfunctiongranted
- Treating Microvascular Dysfunctionapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.